Global Radiocontrast Agent Market Size and Forecast to 2022
![](/report_cover/7525/global-radiocontrast-agent-market-size-n-forecast-to-2022_en.gif)
Radiocontrast Agent Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom,Japan, South Korea and China).
In this report, the global Radiocontrast Agent market is valued at USD XX million in 2018 and is projected to reach USD XX million by the end of 2022, growing at a CAGR of XX% during the period 2018 to 2022.
The report firstly introduced the Radiocontrast Agent basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The major players profiled in this report include:
Daiichi Sankyo
Unijules Life Sciences
Taejoon Pharm
Lantheus
GE Healthcare
Bracco Imaging
Bayer HealthCare
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Barium-based Radiocontrast Agent
Gadolinium-based Radiocontrast Agent
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Radiocontrast Agent for each application, including-
Radiology
Interventional Radiology
Interventional Cardiology
In this report, the global Radiocontrast Agent market is valued at USD XX million in 2018 and is projected to reach USD XX million by the end of 2022, growing at a CAGR of XX% during the period 2018 to 2022.
The report firstly introduced the Radiocontrast Agent basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The major players profiled in this report include:
Daiichi Sankyo
Unijules Life Sciences
Taejoon Pharm
Lantheus
GE Healthcare
Bracco Imaging
Bayer HealthCare
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Barium-based Radiocontrast Agent
Gadolinium-based Radiocontrast Agent
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Radiocontrast Agent for each application, including-
Radiology
Interventional Radiology
Interventional Cardiology
PART I RADIOCONTRAST AGENT INDUSTRY OVERVIEW
CHAPTER ONE RADIOCONTRAST AGENT INDUSTRY OVERVIEW
1.1 Radiocontrast Agent Definition
1.2 Radiocontrast Agent Classification and Prodcut Type Analysis
Barium-based Radiocontrast Agent
Gadolinium-based Radiocontrast Agent
Others
1.3 Radiocontrast Agent Application and Down Stream Market Analysis
Radiology
Interventional Radiology
Interventional Cardiology
1.4 Radiocontrast Agent Industry Chain Structure Analysis
1.5 Radiocontrast Agent Industry Development Overview
1.6 Radiocontrast Agent Global Market Comparison Analysis
1.6.1 Radiocontrast Agent Global Import Market Analysis
1.6.2 Radiocontrast Agent Global Export Market Analysis
1.6.3 Radiocontrast Agent Global Main Region Market Analysis
1.6.4 Radiocontrast Agent Global Market Comparison Analysis
1.6.5 Radiocontrast Agent Global Market Development Trend Analysis
PART II ASIA RADIOCONTRAST AGENT INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER TWO 2013-2018 ASIA RADIOCONTRAST AGENT PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
2.1 2013-2018 Radiocontrast Agent Capacity Production Overview
2.2 2013-2018 Radiocontrast Agent Production Market Share Analysis
2.3 2013-2018 Radiocontrast Agent Demand Overview
2.4 2013-2018 Radiocontrast Agent Supply Demand and Shortage Analysis
2.5 2013-2018 Radiocontrast Agent Import Export Consumption Analysis
2.6 2013-2018 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER THREE ASIA RADIOCONTRAST AGENT KEY MANUFACTURERS ANALYSIS
3.1 Daiichi Sankyo
3.1.1 Product Picture and Specification
3.1.2 Capacity Production Price Cost Production Value Analysis
3.1.3 Contact Information
3.2 Unijules Life Sciences
3.2.1 Product Picture and Specification
3.2.2 Capacity Production Price Cost Production Value Analysis
3.2.3 Contact Information
3.3 Taejoon Pharm
3.3.1 Product Picture and Specification
3.3.2 Capacity Production Price Cost Production Value Analysis
3.3.3 Contact Information
CHAPTER FOUR ASIA RADIOCONTRAST AGENT INDUSTRY DEVELOPMENT TREND
4.1 2018-2022 Radiocontrast Agent Capacity Production Trend
4.2 2018-2022 Radiocontrast Agent Production Market Share Analysis
4.3 2018-2022 Radiocontrast Agent Demand Trend
4.4 2018-2022 Radiocontrast Agent Supply Demand and Shortage Analysis
4.5 2018-2022 Radiocontrast Agent Import Export Consumption Analysis
4.6 2018-2022 Radiocontrast Agent Cost Price Production Value Profit Analysis
PART III NORTH AMERICAN RADIOCONTRAST AGENT INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER FIVE 2013-2018 NORTH AMERICAN RADIOCONTRAST AGENT PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
5.1 2013-2018 Radiocontrast Agent Capacity Production Overview
5.2 2013-2018 Radiocontrast Agent Production Market Share Analysis
5.3 2013-2018 Radiocontrast Agent Demand Overview
5.4 2013-2018 Radiocontrast Agent Supply Demand and Shortage Analysis
5.5 2013-2018 Radiocontrast Agent Import Export Consumption Analysis
5.6 2013-2018 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER SIX NORTH AMERICAN RADIOCONTRAST AGENT KEY MANUFACTURERS ANALYSIS
6.1 Lantheus
6.1.1 Product Picture and Specification
6.1.2 Capacity Production Price Cost Production Value Analysis
6.1.3 Contact Information
6.2 GE Healthcare
6.2.1 Product Picture and Specification
6.2.2 Capacity Production Price Cost Production Value Analysis
6.2.3 Contact Information
CHAPTER SEVEN NORTH AMERICAN RADIOCONTRAST AGENT INDUSTRY DEVELOPMENT TREND
7.1 2018-2022 Radiocontrast Agent Capacity Production Trend
7.2 2018-2022 Radiocontrast Agent Production Market Share Analysis
7.3 2018-2022 Radiocontrast Agent Demand Trend
7.4 2018-2022 Radiocontrast Agent Supply Demand and Shortage Analysis
7.5 2018-2022 Radiocontrast Agent Import Export Consumption Analysis
7.6 2018-2022 Radiocontrast Agent Cost Price Production Value Profit Analysis
PART IV EUROPE RADIOCONTRAST AGENT INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER EIGHT 2013-2018 EUROPE RADIOCONTRAST AGENT PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2013-2018 Radiocontrast Agent Capacity Production Overview
8.2 2013-2018 Radiocontrast Agent Production Market Share Analysis
8.3 2013-2018 Radiocontrast Agent Demand Overview
8.4 2013-2018 Radiocontrast Agent Supply Demand and Shortage Analysis
8.5 2013-2018 Radiocontrast Agent Import Export Consumption Analysis
8.6 2013-2018 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER NINE EUROPE RADIOCONTRAST AGENT KEY MANUFACTURERS ANALYSIS
9.1 Bracco Imaging
9.1.1 Product Picture and Specification
9.1.2 Capacity Production Price Cost Production Value Analysis
9.1.3 Contact Information
9.2 Bayer HealthCare
9.2.1 Product Picture and Specification
9.2.2 Capacity Production Price Cost Production Value Analysis
9.2.3 Contact Information
CHAPTER TEN EUROPE RADIOCONTRAST AGENT INDUSTRY DEVELOPMENT TREND
10.1 2018-2022 Radiocontrast Agent Capacity Production Trend
10.2 2018-2022 Radiocontrast Agent Production Market Share Analysis
10.3 2018-2022 Radiocontrast Agent Demand Trend
10.4 2018-2022 Radiocontrast Agent Supply Demand and Shortage Analysis
10.5 2018-2022 Radiocontrast Agent Import Export Consumption Analysis
10.6 2018-2022 Radiocontrast Agent Cost Price Production Value Profit Analysis
PART V RADIOCONTRAST AGENT MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER ELEVEN RADIOCONTRAST AGENT MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
11.1 Radiocontrast Agent Marketing Channels Status
11.2 Radiocontrast Agent Marketing Channels Characteristic
11.3 Radiocontrast Agent Marketing Channels Development Trend
11.2 New Firms Enter Market Strategy
11.3 New Project Investment Proposals
CHAPTER TWELVE DEVELOPMENT ENVIRONMENTAL ANALYSIS
12.1 China Macroeconomic Environment Analysis
12.2 European Economic Environmental Analysis
12.3 United States Economic Environmental Analysis
12.4 Japan Economic Environmental Analysis
12.5 Global Economic Environmental Analysis
CHAPTER THIRTEEN RADIOCONTRAST AGENT NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
13.1 Radiocontrast Agent Market Analysis
13.2 Radiocontrast Agent Project SWOT Analysis
13.3 Radiocontrast Agent New Project Investment Feasibility Analysis
PART VI GLOBAL RADIOCONTRAST AGENT INDUSTRY CONCLUSIONS
CHAPTER FOURTEEN 2013-2018 GLOBAL RADIOCONTRAST AGENT PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
14.1 2013-2018 Radiocontrast Agent Capacity Production Overview
14.2 2013-2018 Radiocontrast Agent Production Market Share Analysis
14.3 2013-2018 Radiocontrast Agent Demand Overview
14.4 2013-2018 Radiocontrast Agent Supply Demand and Shortage Analysis
14.5 2013-2018 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER FIFTEEN GLOBAL RADIOCONTRAST AGENT INDUSTRY DEVELOPMENT TREND
15.1 2018-2022 Radiocontrast Agent Capacity Production Trend
15.2 2018-2022 Radiocontrast Agent Production Market Share Analysis
15.3 2018-2022 Radiocontrast Agent Demand Trend
15.4 2018-2022 Radiocontrast Agent Supply Demand and Shortage Analysis
15.5 2018-2022 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER SIXTEEN GLOBAL RADIOCONTRAST AGENT INDUSTRY RESEARCH CONCLUSIONS
CHAPTER ONE RADIOCONTRAST AGENT INDUSTRY OVERVIEW
1.1 Radiocontrast Agent Definition
1.2 Radiocontrast Agent Classification and Prodcut Type Analysis
Barium-based Radiocontrast Agent
Gadolinium-based Radiocontrast Agent
Others
1.3 Radiocontrast Agent Application and Down Stream Market Analysis
Radiology
Interventional Radiology
Interventional Cardiology
1.4 Radiocontrast Agent Industry Chain Structure Analysis
1.5 Radiocontrast Agent Industry Development Overview
1.6 Radiocontrast Agent Global Market Comparison Analysis
1.6.1 Radiocontrast Agent Global Import Market Analysis
1.6.2 Radiocontrast Agent Global Export Market Analysis
1.6.3 Radiocontrast Agent Global Main Region Market Analysis
1.6.4 Radiocontrast Agent Global Market Comparison Analysis
1.6.5 Radiocontrast Agent Global Market Development Trend Analysis
PART II ASIA RADIOCONTRAST AGENT INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER TWO 2013-2018 ASIA RADIOCONTRAST AGENT PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
2.1 2013-2018 Radiocontrast Agent Capacity Production Overview
2.2 2013-2018 Radiocontrast Agent Production Market Share Analysis
2.3 2013-2018 Radiocontrast Agent Demand Overview
2.4 2013-2018 Radiocontrast Agent Supply Demand and Shortage Analysis
2.5 2013-2018 Radiocontrast Agent Import Export Consumption Analysis
2.6 2013-2018 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER THREE ASIA RADIOCONTRAST AGENT KEY MANUFACTURERS ANALYSIS
3.1 Daiichi Sankyo
3.1.1 Product Picture and Specification
3.1.2 Capacity Production Price Cost Production Value Analysis
3.1.3 Contact Information
3.2 Unijules Life Sciences
3.2.1 Product Picture and Specification
3.2.2 Capacity Production Price Cost Production Value Analysis
3.2.3 Contact Information
3.3 Taejoon Pharm
3.3.1 Product Picture and Specification
3.3.2 Capacity Production Price Cost Production Value Analysis
3.3.3 Contact Information
CHAPTER FOUR ASIA RADIOCONTRAST AGENT INDUSTRY DEVELOPMENT TREND
4.1 2018-2022 Radiocontrast Agent Capacity Production Trend
4.2 2018-2022 Radiocontrast Agent Production Market Share Analysis
4.3 2018-2022 Radiocontrast Agent Demand Trend
4.4 2018-2022 Radiocontrast Agent Supply Demand and Shortage Analysis
4.5 2018-2022 Radiocontrast Agent Import Export Consumption Analysis
4.6 2018-2022 Radiocontrast Agent Cost Price Production Value Profit Analysis
PART III NORTH AMERICAN RADIOCONTRAST AGENT INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER FIVE 2013-2018 NORTH AMERICAN RADIOCONTRAST AGENT PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
5.1 2013-2018 Radiocontrast Agent Capacity Production Overview
5.2 2013-2018 Radiocontrast Agent Production Market Share Analysis
5.3 2013-2018 Radiocontrast Agent Demand Overview
5.4 2013-2018 Radiocontrast Agent Supply Demand and Shortage Analysis
5.5 2013-2018 Radiocontrast Agent Import Export Consumption Analysis
5.6 2013-2018 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER SIX NORTH AMERICAN RADIOCONTRAST AGENT KEY MANUFACTURERS ANALYSIS
6.1 Lantheus
6.1.1 Product Picture and Specification
6.1.2 Capacity Production Price Cost Production Value Analysis
6.1.3 Contact Information
6.2 GE Healthcare
6.2.1 Product Picture and Specification
6.2.2 Capacity Production Price Cost Production Value Analysis
6.2.3 Contact Information
CHAPTER SEVEN NORTH AMERICAN RADIOCONTRAST AGENT INDUSTRY DEVELOPMENT TREND
7.1 2018-2022 Radiocontrast Agent Capacity Production Trend
7.2 2018-2022 Radiocontrast Agent Production Market Share Analysis
7.3 2018-2022 Radiocontrast Agent Demand Trend
7.4 2018-2022 Radiocontrast Agent Supply Demand and Shortage Analysis
7.5 2018-2022 Radiocontrast Agent Import Export Consumption Analysis
7.6 2018-2022 Radiocontrast Agent Cost Price Production Value Profit Analysis
PART IV EUROPE RADIOCONTRAST AGENT INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER EIGHT 2013-2018 EUROPE RADIOCONTRAST AGENT PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2013-2018 Radiocontrast Agent Capacity Production Overview
8.2 2013-2018 Radiocontrast Agent Production Market Share Analysis
8.3 2013-2018 Radiocontrast Agent Demand Overview
8.4 2013-2018 Radiocontrast Agent Supply Demand and Shortage Analysis
8.5 2013-2018 Radiocontrast Agent Import Export Consumption Analysis
8.6 2013-2018 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER NINE EUROPE RADIOCONTRAST AGENT KEY MANUFACTURERS ANALYSIS
9.1 Bracco Imaging
9.1.1 Product Picture and Specification
9.1.2 Capacity Production Price Cost Production Value Analysis
9.1.3 Contact Information
9.2 Bayer HealthCare
9.2.1 Product Picture and Specification
9.2.2 Capacity Production Price Cost Production Value Analysis
9.2.3 Contact Information
CHAPTER TEN EUROPE RADIOCONTRAST AGENT INDUSTRY DEVELOPMENT TREND
10.1 2018-2022 Radiocontrast Agent Capacity Production Trend
10.2 2018-2022 Radiocontrast Agent Production Market Share Analysis
10.3 2018-2022 Radiocontrast Agent Demand Trend
10.4 2018-2022 Radiocontrast Agent Supply Demand and Shortage Analysis
10.5 2018-2022 Radiocontrast Agent Import Export Consumption Analysis
10.6 2018-2022 Radiocontrast Agent Cost Price Production Value Profit Analysis
PART V RADIOCONTRAST AGENT MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER ELEVEN RADIOCONTRAST AGENT MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
11.1 Radiocontrast Agent Marketing Channels Status
11.2 Radiocontrast Agent Marketing Channels Characteristic
11.3 Radiocontrast Agent Marketing Channels Development Trend
11.2 New Firms Enter Market Strategy
11.3 New Project Investment Proposals
CHAPTER TWELVE DEVELOPMENT ENVIRONMENTAL ANALYSIS
12.1 China Macroeconomic Environment Analysis
12.2 European Economic Environmental Analysis
12.3 United States Economic Environmental Analysis
12.4 Japan Economic Environmental Analysis
12.5 Global Economic Environmental Analysis
CHAPTER THIRTEEN RADIOCONTRAST AGENT NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
13.1 Radiocontrast Agent Market Analysis
13.2 Radiocontrast Agent Project SWOT Analysis
13.3 Radiocontrast Agent New Project Investment Feasibility Analysis
PART VI GLOBAL RADIOCONTRAST AGENT INDUSTRY CONCLUSIONS
CHAPTER FOURTEEN 2013-2018 GLOBAL RADIOCONTRAST AGENT PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
14.1 2013-2018 Radiocontrast Agent Capacity Production Overview
14.2 2013-2018 Radiocontrast Agent Production Market Share Analysis
14.3 2013-2018 Radiocontrast Agent Demand Overview
14.4 2013-2018 Radiocontrast Agent Supply Demand and Shortage Analysis
14.5 2013-2018 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER FIFTEEN GLOBAL RADIOCONTRAST AGENT INDUSTRY DEVELOPMENT TREND
15.1 2018-2022 Radiocontrast Agent Capacity Production Trend
15.2 2018-2022 Radiocontrast Agent Production Market Share Analysis
15.3 2018-2022 Radiocontrast Agent Demand Trend
15.4 2018-2022 Radiocontrast Agent Supply Demand and Shortage Analysis
15.5 2018-2022 Radiocontrast Agent Cost Price Production Value Profit Analysis
CHAPTER SIXTEEN GLOBAL RADIOCONTRAST AGENT INDUSTRY RESEARCH CONCLUSIONS